+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Treatment of pigs experimentally infected with Mycoplasma hyopneumoniae, Pasteurella multocida, and Actinobacillus pleuropneumoniae with various antibiotics



Treatment of pigs experimentally infected with Mycoplasma hyopneumoniae, Pasteurella multocida, and Actinobacillus pleuropneumoniae with various antibiotics



Canadian Journal of Veterinary Research 65(4): 213-222



The authors have performed a comparative study of the efficacy of various in-feed medications for the treatment of 5- to 6-week-old specific pathogen-free (SPF) piglets experimentally infected on day 1 with Mycoplasma hyopneumoniae, on day 8 with Pasteurella multocida (serotype A), and on day 15 with Actinobacillus pleuropneumoniae (serotype 2). The treatment started on day 9 and continued for 12 consecutive days, then the piglets were euthanized for examination of macroscopic, histologic, and pathologic lesions and for the presence of mycoplasmas and bacteria in the lungs. Based on the results of clinical observations (respiratory signs, rectal temperature, body weight gain, and feed conversion efficiency), macroscopic and histologic lesions of the lungs, and microbiologic findings, the best results were obtained by treatment of pigs with Econor + chlortetracycline, followed by Tetramutin, Pulmotil, Cyfac, and lincomycin + chlortetracycline.

(PDF emailed within 1 workday: $29.90)

Accession: 047835899

Download citation: RISBibTeXText

PMID: 11768127


Related references

Efficacy of Tiamutin + CTC, lincomycin + CTC, Econor + CTC and tilmicosin in treatment of piglets experimentally infected with Mycoplasma hyopneumoniae, Pasteurella multocida and Actinobacillus pleuropneumoniae. Journal of Veterinary Pharmacology & Therapeutics 20(SUPPL 1): 131, 1997

Evaluation of serovar-independent ELISA antigens of Actinobacillus pleuropneumoniae in pigs, following experimental challenge with A. pleuropneumoniae, Mycoplasma hyopneumoniae and Pasteurella multocida. Australian Veterinary Journal 90(6): 225-234, 2012

Antibody response in sows and piglets following vaccination against Mycoplasma hyopneumoniae, toxigenic Pasteurella multocida, and Actinobacillus pleuropneumoniae. Canadian Journal of Veterinary Research 68(1): 66-70, 2004

Serological patterns of Actinobacillus pleuropneumoniae, Mycoplasma hyopneumoniae, Pasteurella multocida and Streptococcus suis in pig herds affected by pleuritis. Acta Veterinaria Scandinavica 58(1): 71, 2017

The use of experimental models to study in vivo the antibacterial activity of enrofloxacin against Actinobacillus (Haemophilus) pleuropneumoniae and Mycoplasma hyopneumoniae in combination with Pasteurella multocida. Proceedings, International Pig Veterinary Society, 11th Congress, July 1-5, 1990, Lausanne, Switzerland: 16, 1990

Diagnosis and treatment of certain infections caused by Mycoplasma hyopneumoniae, Pasteurella multocida and Escherichia coli in pigs. Revista Romana de Medicina Veterinara 16(2): 99-108, 2006

Evaluation of the RapID NH system for identification of Haemophilus somnus, Pasteurella multocida, Pasteurella haemolytica, and Actinobacillus pleuropneumoniae isolated from cattle and pigs with respiratory disease. Journal of Clinical Microbiology 31(5): 1362-1363, 1993

Experimental infection of SPF pigs with Actinobacillus pleuropneumoniae serotype 9 alone or in association with Mycoplasma hyopneumoniae. Veterinary Microbiology 135(3-4): 283-291, 2008

Potential synergism between Aujeszky virus, Mycoplasma hyopneumoniae and Actinobacillus pleuropneumoniae in fattening pigs. Tecnica Pecuaria en Mexico 37(1): 23-30, 1999

Field efficacy of a combined use of Mycoplasma hyopneumoniae and Actinobacillus pleuropneumoniae vaccines in growing pigs. Preventive Veterinary Medicine 39(1): 13-24, 1999

Antimicrobial susceptibility of Actinobacillus pleuropneumoniae, Pasteurella multocida and Salmonella choleraesuis isolates from pigs. Veterinary Record 134(1): 5-7, 1994

Efficacy of Mycoplasma hyopneumoniae inactivated vaccine against experimental dual infection with Mycoplasma hyopneumoniae and Pasteurella multocida. Journal of the Japan Veterinary Medical Association 56(8): 522-527, 2003

In vitro-antibacterial properties of tilmicosin against Australian isolates of Pasteurella multocida and Actinobacillus pleuropneumoniae from pigs. Australian Veterinary Journal 72(1): 35-36, 1995

Mycoplasma hyopneumoniae increases the susceptibility of pigs to experimental Pasteurella multocida pneumonia. Canadian Journal of Veterinary Research 52(4): 434-438, 1988

Antimicrobial resistance genes in Actinobacillus pleuropneumoniae, Haemophilus parasuis and Pasteurella multocida isolated from Australian pigs. Australian Veterinary Journal 94(7): 227-231, 2017